PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 1.56 AUD 3.31% Market Closed
Market Cap: 909.9m AUD

Wall Street
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 3.72 AUD with a low forecast of 2.32 AUD and a high forecast of 5.33 AUD.

Lowest
Price Target
2.32 AUD
49% Upside
Average
Price Target
3.72 AUD
138% Upside
Highest
Price Target
5.33 AUD
242% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
STOK
Stoke Therapeutics Inc
4% Upside
INSM
Insmed Inc
24% Upside
RCUS
Arcus Biosciences Inc
44% Upside
300896
Imeik Technology Development Co Ltd
40% Upside
ALEC
Alector Inc
48% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
61% Upside
RXRX
Recursion Pharmaceuticals Inc
64% Upside
9966
Alphamab Oncology
9% Downside

Revenue
Forecast

Revenue Estimate
PYC Therapeutics Ltd

For the last 13 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 22%. The projected CAGR for the next 3 years is 98%.

22%
Past Growth
98%
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Operating Income
Forecast

Operating Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

Net Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PYC's stock price target?
Price Target
3.72 AUD

According to Wall Street analysts, the average 1-year price target for PYC is 3.72 AUD with a low forecast of 2.32 AUD and a high forecast of 5.33 AUD.

What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
98%

For the last 13 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 22%. The projected CAGR for the next 3 years is 98%.

Back to Top